Category: 4. Technology

  • Yooka-Laylee remaster comes to consoles and PC on October 9

    Yooka-Laylee remaster comes to consoles and PC on October 9

    Yooka-Replaylee, , will be available on October 9. It’ll be playable on PC, Xbox Series X/S, PS5 and Switch 2. It’s getting both a digital and physical release, and preorders for the physical versions are up right now.

    Speaking of physical copies, the Switch 2 version will include the full game on the cartridge and no game-key card. Nintendo has given developers the option to release cartridges that are basically empty shells, called game-key cards, that require an immediate download upon being slotted in the console. Collectors aren’t exactly keen on this practice, so an actual cartridge release for Yooka-Replaylee is a welcome bit of news.

    This is a remade and enhanced version of Yooka-Laylee, which was itself an like Banjo-Kazooie. Developer Playtonic is staffed with people who worked on Rare titles like the aforementioned Banjo and the Donkey Kong Country games.

    Yooka-Replaylee brings some new features to the table, including updated challenges, a fully orchestral soundtrack and, of course, more stuff to collect. There’s also a bigger map, a refined story and enhanced graphics. It looks pretty nifty.

    The digital version of the game will cost $30, while physical copies will cost $50. There’s a promotion going for long-time fans, as those who already own the game will get 30 percent off so long as they buy the remaster on the same platform family as the original. This means Switch to Switch 2, PS4 to PS5 and Xbox One to Xbox Series X/S.

    Continue Reading

  • How to use Instapaper on Kobo to save and read online articles

    How to use Instapaper on Kobo to save and read online articles

    When Pocket shut down earlier this year, it hurt more than just folks who wanted to save articles easier. Kobo users could no longer read articles directly from the internet on their eReader — a devastating move for so many readers like myself.

    Kobo recently announced it would replace Pocket with Instapaper, a minimalist and sleek service much like Pocket that offers both a free plan as well as a paid premium subscription option, saving us from having to read articles the second we see them. And, on Thursday, that update came to users.

    “At Kobo, our passion is better reading for everyone, everywhere.  And now, with the addition of Instapaper’s excellent ‘read it later’ functionality, we have a perfect solution to the long-form reading you find on the web,” Michael Tamblyn, the CEO of Rakuten Kobo said in a press release on Thursday. “When Pocket unexpectedly sunset, we knew we had to find a new way for our readers to dive into their favourite web articles right on their Kobo. Partnering with Instapaper has been a dream, the team has been great to work with, and we’re thrilled to offer this integration so readers can keep enjoying their preferred long-form content, distraction-free, on their Kobo eReader.”

    Mashable Light Speed

    Here’s how to download articles directly from the internet onto your Kobo with Instapaper.

    SEE ALSO:

    Where to get free e-books: Load up your e-reader without spending a dime

    Step 1:
    Navigate to “My Articles”

    Click the hamburger menu titled “More” in the bottom right of your Kobo and click “My Articles.”

    Step 2:
    Link with Instapaper

    Once you click “My Articles,” you’ll be met with a page that reads: “read articles on your eReader with Instapaper.” “Find something you want to view later? Save it in Instapaper and enjoy it on your Kobo eReader, phone, tablet, and computer whenever you’re ready — even offline.” Click “Link with Instapaper” and follow the directions on your eReader, including using your phone to scan a QR code or entering a code at kobo.com/instapaper.

    Step 3:
    Sync it up

    After you link your Kobo with Instapaper, stay on a WiFi network to sync all your saved articles on Instapaper to your Kobo, and voila! Your articles are there and saved for you to read any time.

    If there isn’t an option for you to view your articles when you click “more,” you’ll need to update your Kobo. It shouldn’t take too long, and when it starts back up it’ll show you exactly what the update is there for: “Farewell to Pocket,” and “Hello to Instapaper.”

    If you want to keep all your data from Pocket on your Instapaper, you can do that, too. Simply export your Pocket data and import it to Instapaper.

    Now there’s really no excuse to have that many tabs open.

    Continue Reading

  • Qualcomm’s Snapdragon 8 Elite 2 may not be called that

    Qualcomm’s Snapdragon 8 Elite 2 may not be called that

    In late September, Qualcomm will unveil its next-gen flagship chipset, the successor to the Snapdragon 8 Elite from last year. We’ve been tentatively calling this the Snapdragon 8 Elite 2, but today a new rumor out of China claims that might not be its name at all.

    Instead, Qualcomm could opt for the initially much more confusing Snapdragon 8 Elite Gen 5. There are two reasons for this, if it does pan out. First, while “Gen 5” sounds weird since the 8 Elite only came out last year, that chip was actually the successor to the 8 Gen 3 (so it’s “Gen 4” despite not being called that).

    The other reason has to do with the much rumored fact that Qualcomm will release an almost-flagship chipset too this year, which it may call Snapdragon 8 Gen 5. This will sit right below the 8 Elite Gen 5, and with all this knowledge the naming does start to make more sense.

    Note that the 8 Gen 5 is different from the 8s Gen 5, being higher-end than that while still not quite reaching the level of the 8 Elite Gen 5. Anyway, the 8 Elite Gen 5 was just benchmarked inside the upcoming OnePlus 15.

    Source (in Chinese)

    Continue Reading

  • 75% of Cyberpunk 2077: Ultimate Edition Nintendo Switch 2 Sales Were Physical, CD Projekt Reveals

    75% of Cyberpunk 2077: Ultimate Edition Nintendo Switch 2 Sales Were Physical, CD Projekt Reveals

    75% of Cyberpunk 2077‘s Nintendo Switch 2 sales were physical, CD Projekt has confirmed.

    CD Projekt revealed the eye-catching stat in its latest financial results, confirming that not only did the action-RPG benefit from positioning itself as one of Nintendo Switch 2’s day-one launch games, but it also found success by making the game available as physical media.

    “We believe that thanks to its high quality and Switch 2 exclusive enhancements, Cyberpunk 2077 Ultimate Edition is well positioned to benefit from the [Switch 2’s] growing user base,” said Michał Novakovski, joint CEO. “As of June, the vast majority of sales — which is around 70% — came from physical copies sold and that reflects the strength of our offering.”

    Switch 2 owners preferred the physical version of Cyberpunk 2077.

    Novakovski believes this is, in part, because “the entire game, along with its expansion, is fully contained on a 64 gigabyte cartridge, providing a plug and play experience which players find particularly attractive.” And that has certainly proven to be the case, with 75.4% of all Cyberpunk 2077’s Switch 2 sales being physical.

    It comes as fans continue to debate the practice of publishers providing Game-Key Cards in Switch 2 boxed games instead of a physical cartridge. It’s proven to be a divisive practice among some users, not least because while it allows collectors to have a game’s box on their shelf, they’re essentially useless unless your console is connected to the internet.

    The practice is so controversial, however, that Nintendo has launched a survey designed to poll the Switch 2 userbase on its thoughts surrounding digital and physical games, with questions designed to probe the reasons you might consider one option over another. Nintendo’s also interested in finding out if your attitude to digital downloads has shifted over time.

    “Our developers truly made the most of the console’s features, offering new exclusive ways to play Cyberpunk 2077,” Novakovski added. “We showcased them in a series of hands on presentations attracting praise from the player community and gaming media. And although we clearly see that sales of the on the new console are currently dominated by Nintendo’s first party titles, we were very pleased with Cyberpunk being among the best selling third party games.”

    “The Switch 2 might pack much better hardware than the original, but a game I’m still surprised to see running at all (much less pretty well) on a Nintendo system is Cyberpunk 2077,” we wrote in our Nintendo Switch 2 Cyberpunk 2007 review update. “I spent a few days with CD Projekt Red’s latest port to get a feel for how it runs, how it holds up, and how the Switch 2’s fancy new mouse controls work when applied to a high-octane FPS. The answer across the board is impressive, and if you haven’t had the pleasure of exploring Night City before, this seems like a solid way to do so.”

    Cyberpunk 2077 sequel Cyberpunk 2 has officially entered pre-production. The studio made the announcement as part of its latest financial results last month, where it said the Phantom Liberty expansion for Cyberpunk 2077 had hit an impressive 10 million copies sold.

    As for Nintendo’s handheld itself? The Nintendo Switch 2 debuted in June to become the fastest-selling hardware ever in the U.S., shooting spending on games to new records. Spending on hardware was up a whopping 249% year-over-year thanks to the console’s debut, reaching $978 million and greatly surpassing the previous monthly record from June 2008 of $608 million. In total, the Switch 2 sold 1.6 million units in the U.S. during its launch month, beating the PlayStation 4’s previous sales record of 1.1 million units in November of 2013.

    Vikki Blake is a reporter for IGN, as well as a critic, columnist, and consultant with 15+ years experience working with some of the world’s biggest gaming sites and publications. She’s also a Guardian, Spartan, Silent Hillian, Legend, and perpetually High Chaos. Find her at BlueSky.

Continue Reading

  • Researchers Warn of Sitecore Exploit Chain Linking Cache Poisoning and Remote Code Execution

    Researchers Warn of Sitecore Exploit Chain Linking Cache Poisoning and Remote Code Execution

    Aug 29, 2025Ravie LakshmananVulnerability / Web Security

    Three new security vulnerabilities have been disclosed in the Sitecore Experience Platform that could be exploited to achieve information disclosure and remote code execution.

    The flaws, per watchTowr Labs, are listed below –

    • CVE-2025-53693 – HTML cache poisoning through unsafe reflections
    • CVE-2025-53691 – Remote code execution (RCE) through insecure deserialization
    • CVE-2025-53694 – Information Disclosure in ItemService API with a restricted anonymous user, leading to exposure of cache keys using a brute-force approach

    Patches for the first two shortcomings were released by Sitecore in June and for the third in July 2025, with the company stating that “successful exploitation of the related vulnerabilities might lead to remote code execution and non-authorized access to information.”

    Identity Security Risk Assessment

    The findings build on three more flaws in the same product that were detailed by watchTowr back in June –

    • CVE-2025-34509 (CVSS score: 8.2) – Use of hard-coded credentials
    • CVE-2025-34510 (CVSS score: 8.8) – Post-authenticated remote code execution via path traversal
    • CVE-2025-34511 (CVSS score: 8.8) – Post-authenticated remote code execution via Sitecore PowerShell Extension

    watchTowr Labs researcher Piotr Bazydlo said the newly uncovered bugs could be fashioned into an exploit chain by bringing together the pre-auth HTML cache poisoning vulnerability with a post-authenticated remote code execution issue to compromise a fully-patched Sitecore Experience Platform instance.

    The entire sequence of events leading up to code execution is as follows: A threat actor could leverage the ItemService API, if exposed, to trivially enumerate HTML cache keys stored in the Sitecore cache and send HTTP cache poisoning requests to those keys.

    This could then be chained with CVE-2025-53691 to supply malicious HTML code that ultimately results in code execution by means of an unrestricted BinaryFormatter call.

    “We managed to abuse a very restricted reflection path to call a method that lets us poison any HTML cache key,” Bazydlo said. “That single primitive opened the door to hijacking Sitecore Experience Platform pages – and from there, dropping arbitrary JavaScript to trigger a Post-Auth RCE vulnerability.”

    Continue Reading

  • Rethink Light, Reimagine Style — Olight Unveils ArkPro Series with Groundbreaking Pure Flood

    Rethink Light, Reimagine Style — Olight Unveils ArkPro Series with Groundbreaking Pure Flood

    NEW YORK, Aug. 29, 2025 /PRNewswire/ — Olight, a global innovator in portable lighting, unveiled the ArkPro Series at the seventh annual O-Fan Day. The series — ArkPro, ArkPro Ultra, and ArkPro Lite — features a sleek flat-body design with multi-tool versatility and industry-first innovations, setting a new standard for everyday carry lighting. It will debut in Europe at IFA Berlin 2025, showcasing Olight’s lighting innovations worldwide.

    Rethink Light: 4 Sources, Endless Versatility

    The ultimate 4-in-1 EDC flashlight, the ArkPro features Pure Flood, spotlight, UV, and green laser. It delivers up to seven lighting modes, redefining handheld lighting with unmatched versatility for work, play, lifestyle, and gifting.

    Among the ArkPro Series’ most groundbreaking innovations is Pure Flood, lighting concept pioneered by Olight and the first in the industry. Unlike conventional beams with glaring hotspots or harsh edges, Pure Flood provides a seamless, boundary-free wash of light that feels as natural as daylight, perfect for camping, workspaces, or city exploration. Smooth and immersive — you might forget you’re holding a flashlight.

    The ArkPro Ultra introduces exclusive enhancements with Olight’s self-developed EIP 1 LED, delivering clean light with a Duv below 0.006 at all brightness levels. With 134 lm/W efficiency — 10% higher than other high-output LEDs — it sets a new benchmark for EDC lighting performance.

    Reimagine Style: Innovative Design and Collectible Appeal

    Olight flashlights have long turned utility into artistry, and the ArkPro Series advances this with the industry-first dual-tone Silver Graphite finish on a flat, unibody aluminum design — seamless, robust, and heat-efficient.

    World-class industrial design extends to every detail: the ArkPro Series features precision laser-etched indicators and a smooth rotary selector, while micro-perforated dual-color LED indicators set a new benchmark for functional aesthetics.

    The ArkPro Ultra elevates design to a dynamic experience with ArkBeat, a subtle breathing-pulse light that shifts color over time, transforming a high-performance tool into a living, collectible companion. Lightweight, elegant, and personalized, making it a standout choice for EDC enthusiasts and a perfect gift.

    Everyday Versatility: Performance Meets Lifestyle

    “The ArkPro Series sets a new standard for handheld lighting, merging advanced photonics with aerospace-grade materials and sleek design,” said Mavis Xiao, CMO of Olight. “From outdoor freedom to urban confidence, ArkPro is more than a tool — it’s a companion that brightens every journey. Each beam delivers more than light — it carries imagination, style, and inspires a new way of living.”

    Full specifications can be found at OLIGHT® | Global Leader in Portable Lighting Industry- Olight.

    About Olight

    Founded in 2007, Olight is a global innovator in portable lighting, offering a diverse range of pioneering, high-tech products for EDC, outdoor, home and garden, tactical use, and more. With over 1,200 patents and accolades from the iF Design and Red Dot Awards, Olight’s global reach extends to over 100 countries. In 2024, Olight unveiled the world’s first flashlight experience store in Las Vegas, boldly reaffirming its commitment to driving the industry forward.

    Media Contact: [email protected] 

    SOURCE Olight Group Co.,Ltd

    Continue Reading

  • Could Google Chrome soon be OpenAI Chrome?

    Could Google Chrome soon be OpenAI Chrome?

    AI companies are throwing multi-billion dollar offers at Google with one goal in mind: Acquiring the search giant’s web browser Google Chrome.

    Perplexity AI recently offered more than $34 billion to Google for Chrome. OpenAI, which has much larger coffers, has also expressed strong interest in buying the web browser.

    But, why are all these massive AI companies offering to throw money at Google for a web browser? Is Google Chrome even for sale?

    Here’s why AI companies are offering big bucks for Chrome

    Google’s Chrome web browser has a massive user base, with close to 3.5 billion users. Chrome dominates the search space, making up around 68 percent of the web browser market share

    Chrome is a huge part of Google’s operation, so it is very unlikely that Google would be looking to sell its Chrome web browser – by choice.

    Last year, Google lost a huge antitrust case brought by the U.S. Department of Justice that found that the Big Tech company violated federal law in order to maintain a monopoly in online search.

    Mashable Light Speed

    As a result of losing the antitrust case, the judge will look to break up Google, forcing the company to break their hold over the industry. One recommendation that the DOJ has made to the judge: Force Google to sell its Chrome web browser.

    The courts have yet to make their decision, but the very thought of Google being forced to put Chrome up for sale has AI companies salivating at the thought of acquiring it.

    Why is Google Chrome so important to Google and the AI companies?

    Google Chrome’s dominance in the web browser space is significant, but why is it so integral to Google? 

    Google controls the internet’s most popular web browser. Google makes its search product the default search engine on Chrome. Google maintains its search engine dominance. Google’s search product, its primary source of revenue, brings in hundreds of billions of dollars per year.

    As for the AI companies? AI giants like OpenAI and Perplexity would love to have direct access to that user base, as they look to integrate AI agents into web browsers. The vision for many AI companies is for users to be able to access AI chatbots and all of their functions directly from a web browser, without any need to login to a website or platform. Furthermore, AI companies would love to own that user data in order to better train their AI chatbots. In fact, some AI companies have already launched their own web browsers in order to see these things come to fruition. However, it’ll be a long while before any of these browsers see anything close to Chrome’s market dominance, if at all.

    So, the real question though, is whether Google will actually have to sell Chrome. The judge will likely make their decision soon. However, Tom’s Guide spoke with one expert, Info-Tech Research Group analyst Thomas Randall, who pointed out that it’s unlikely that federal regulators would approve the sale of Google Chrome to another tech giant, regardless of whether they are in the search or AI space.

    Whatever the court decides, Google will likely fight to the end to keep Chrome and appeal the decision.

    Continue Reading

  • Cytoprotective Agent RNS60 Receives Fast Track Designation for Ischemic Stroke Treatment

    Cytoprotective Agent RNS60 Receives Fast Track Designation for Ischemic Stroke Treatment

    In recent news, the FDA has granted fast track designation to Revalesio’s RNS60, an oxygen-supersaturated saline solution with neuroprotective effects, for the treatment of ischemic stroke. While most stroke care focuses on restoring blood flow, this agent offers a novel, cytoprotective strategy, potentially shielding vulnerable brain tissue even after blood flow is restored.1

    RNS60, a physically modified saline engineered to deliver elevated oxygen levels in tandem with saline, is currently being assessed in a phase 3 study of ischemic stroke, dubbed RESTORE. Backed by preclinical data and previously reported phase 2 evidence showing reduced infarct level and improved functional outcomes, RNS60 has potential to be a leading therapy in stroke-related neuroprotection.

    “The Fast Track designation underscores the urgent need for new treatments that go beyond restoring blood flow to actually protect brain tissue and preserve neurological function,” Jordan Dubow, chief medical officer at Revalesio, said in a statement.1 “We believe RNS60 represents a fundamentally different approach to stroke care, and this designation reinforces the importance of advancing it as quickly as possible.”

    RNS60’s mechanism of action allows it to support mitochondrial function, enabling cellular energy production, as well as modulate inflammation, especially in glial cells like microglia and oligodendrocytes. In addition, the agent is designed to activate intracellular survival pathways, such as the Type 1A PI3K signaling pathway, which promotes cell resilience, anti-inflammatory responses, and mitochondrial biogenesis.

    READ MORE: FDA Denies Approval for Friedreich Ataxia Agent Vatiquinone, Citing More Efficacy Needed

    For stroke trials, the drug was previously tested in the phase 2 RESCUE study (NCT04693715), a randomized, double-blind, placebo-controlled trial of patients with acute ischemic stroke due to large vessel occlusion undergoing endovascular thrombectomy (EVT). The trial featured 82 patients who were randomized to either intravenous (IV) RNS60 0.5 mL/kg/h (low dose), RNS60 1.0 mL/kg/h (high dose), or placebo starting before completion of EVT.2

    Findings presented earlier this year at the 2025 American Academy of Neurology (AAN) Annual Meeting revealed a 4.8-day reduction in the average amount of time spent in a hospital for those on RNS60 plus standard of care (SOC) vs those on placebo (P = .022). Those in the high-dose cohort demonstrated a 50% attenuation in infarct growth, which was considered statistically significant (P <.05).3

    At day 90, outcomes favored the RNS60 high-dose cohort, with 72% achieving functional independence compared with 37% on placebo. This group also showed a 16% higher proportion of patients with an mRS of 0–2 (OR, 3.7; P = .36), along with better measures of daily functioning, including a greater percentage with Barthel Index scores >95 (71% vs 43%; OR, 5.8; P = .13) and higher EQ-5D-5L index values (0.74 [±0.13] vs 0.58 [±0.13]; P = .09). Additionally, patients receiving high-dose RNS60 demonstrated improvements in NIHSS scores compared with placebo, supporting consistent benefit across multiple endpoints.

    RNS60 remains in development for other neurologic conditions including amyotrophic lateral sclerosis (ALS) and Alzheimer disease (AD). In a previous phase 2 study of patients with ALS (n = 142), RNS60 showed an ability to help improve respiratory and bulbar function. Over the 24-week treatment period, patients on the agent had slower decline in forced vital capacity compared with placebo (difference, 0.41 per week; P = .0101) and significant improvement in eating and drinking domain of the ALS Assessment Questionnaire (difference, –0.19; P = .0319). Notably, a post-hoc analysis revealed stable levels of neurofilament light chain in bulbar-onset patients with RNS60.3

    REFERENCES
    1. Revalesio Receives FDA Fast Track Designation for RNS60 for the Treatment of Acute Ischemic Stroke. News release. Revalesio. July 31, 2025. Accessed August 28, 2025. https://www.prnewswire.com/news-releases/revalesio-receives-fda-fast-track-designation-for-rns60-for-the-treatment-of-acute-ischemic-stroke-302517694.html
    2. Ghosh S, Dubow J, Sutherland J, et al. RESCUE: A Proof-of-Concept Trial with Adjunct RNS60 Treatment Shows Safety, Reduced Infarct Growth, and Numerical Improvement in all Prespecified Efficacy Endpoints in Participants with Acute Ischemic Stroke. Presented at: 2025 AAN Annual Meeting. ABSTRACT 004832
    3. Pupillo E, Bianchi E, Bonetto V, et al. Long-term survival of participants in a phase II randomized trial of RNS60 in amyotrophic lateral sclerosis. Brain, Behav, and Immunity. 2024;122(456-462). doi:10.1016/j.bbi.2024.08.044

    Continue Reading

  • AI-based program designs new mRNA

    AI-based program designs new mRNA

    A new artificial intelligence–guided design program is coming to messenger RNA (mRNA).

    In a new paper published in Science, researchers from the company Raina Biosciences have detailed their new AI-based design program, called GEMORNA, which can provide mRNA sequences to be used in a broad array of applications, from personalized vaccines to cancer therapies (2025, DOI: 10.1126/science.adr8470).

    Designing an mRNA molecule is more complicated than stringing codons together and feeding that strand to a ribosome. Multiple combinations of coding sequences and untranslated regions can yield the same protein. The goal with mRNA design is to come up with the most efficient combination of coding sequences and untranslated regions to get the desired protein.

    But the design process can be slow going, with trial and error often needed to find the best arrangement.

    “Over the last decade or so, traditional strategies for designing mRNA really have been quite laborious,” says Timothy Lu, cofounder and chairman of Raina. The team, he says, has developed “a generative AI platform that’s trained on massive datasets of mRNA that allows you to essentially do what we call zero-shot optimization of mRNA medicines.”

    In a nutshell, Raina’s GEMORNA can generate an mRNA coding sequence from a given protein sequence in a matter of hours. Untranslated regions are generated by a separate program and are joined to the mRNA by humans. In this case, “zero-shot” means that the program doesn’t need anything else besides the protein sequence to give a result.

    “We can optimize things like durability, expression levels, and other functionalities using this really powerful algorithm, and that allows us to potentially significantly shorten the time it takes to design and optimize a given mRNA therapeutic, as well as achieve superior performance,” Lu says.

    One of the most appealing ways to apply this technology would be making personalized cancer vaccines. Lu says that in these cases, there isn’t time to do a lot of trial and error on what mRNA sequence would be best, but a program that optimizes the mRNA sequence early could cut out a lot of unnecessary work.

    AI-based mRNA design has been around since 2023, says Helen Gunter, a senior postdoctoral fellow at the Australian Institute for Bioengineering and Nanotechnology. But “GEMORNA is one of the first comprehensive mRNA design platforms, able to optimize coding and untranslated regions in parallel,” Gunter writes in an email.

    Gunter notes that GEMORNA’s outputs are still variable, and some human effort is still needed to screen the multiple generated designs. Additionally, these designs may be difficult to produce on a large scale because they may not be well suited to using the common polymerase chain reaction–amplified template method.

    Continue Reading

  • Konami Hopes To Revive ‘Metal Gear’ Game Franchise – Bloomberg.com

    Konami Hopes To Revive ‘Metal Gear’ Game Franchise – Bloomberg.com

    1. Konami Hopes To Revive ‘Metal Gear’ Game Franchise  Bloomberg.com
    2. If Metal Gear Solid Delta: Snake Eater Is Successful Its Producers ‘Would Like To Consider Lots Of Other Games In The Future’  Game Informer
    3. Update Incoming for Metal Gear Solid Delta – PS5 Performance Not Addressed  The Hans India
    4. How to unlock Taste The Poison achievement in Metal Gear Solid Delta Snake Eater  Times of India
    5. Metal Gear Solid Delta: Snake Eater Update 1.1.2 Fixes Crashes and Gameplay Bugs  Twisted Voxel

    Continue Reading